European equities traded in the US as American depositary receipts were modestly higher late Thursday morning, rising 0.18% to 1,482.59 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by semiconductor company Sequans Communications (SQNS) and biopharmaceutical company DBV (DBVT), which advanced 12% and 4.4% respectively. They were followed by accommodations booking site trivago (TRVG) and internet browser company Opera (OPRA), which increased 3.4% and 1.8%.
The decliners from continental Europe were led by financial services company ING (ING), which 0.6%. Also declining were oil and gas company Eni (E) and brewing company Anheuser-Busch InBev (BUD), which lost 0.5% and 0.2%.
From the UK and Ireland, the gainers were led by biopharmaceutical companies Amarin (AMRN) and Akari Therapeutics (AKTX), which rose 4% and 1.8% respectively. Also climbing were software firm Endava (DAVA) medical device maker Smith & Nephew (SNN), which were up 2.5% and 1.1%.
The decliners from the UK and Ireland were led by biopharmaceutical companies NuCana (NCNA) and Adaptimmune Therapeutics (ADAP), which dropped 24% and 2.9% respectively. They were followed by mining company BHP Group (BHP) and biopharmaceutical company Biodexa Pharmaceuticals (BDRX), which were down 1.2% and nearly 1% respectively.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。